Literature DB >> 28645792

Vaginal Salpingectomy Techniques in the Presence of Ovarian Conservation.

Jeffrey L Cornella1.   

Abstract

STUDY
OBJECTIVE: To demonstrate vaginal salpingectomy techniques in the presence of ovarian conservation.
DESIGN: Technical video demonstrating 2 methods of Fallopian tube removal with illustrations (Canadian Task Force classification III).
SETTING: The prevalence of salpingectomy at the time of hysterectomy has increased significantly since 1998 [1]. One reason for the increased rate of salpingectomy is the relationship of serous ovarian carcinomas to fimbrial serous tubal intraepithelial carcinomas [2]. A Swedish population-based study reported that salpingectomy is an effective measure to reduce ovarian cancer risk in the general population [3]. Prophylactic salpingectomy and delayed oophorectomy may be an acceptable alternative in some BRCA mutation carriers [4]. A retrospective cohort study of 425 vaginal hysterectomies showed that 88% of patients were able to successfully undergo concomitant salpingectomy [5]. Mayo Clinic Institutional Review Board approval was not required for this video article. INTERVENTION: Two methods of salpingectomy are demonstrated differing in the final disposition of the proximal Fallopian tube (segment). The 2 different methods are shown to increase clarity and understanding of the technique.
CONCLUSION: Salpingectomy without concomitant removal of the ovaries at vaginal hysterectomy is a feasible and beneficial procedure.
Copyright © 2017 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Salpingectomy; Salpingectomy techniques; Vaginal salpingectomy

Mesh:

Year:  2017        PMID: 28645792     DOI: 10.1016/j.jmig.2017.06.012

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  1 in total

1.  Adnexectomy at the time of vaginal hysterectomy for pelvic organ prolapse.

Authors:  Emily A Slopnick; David D Sheyn; Graham C Chapman; Sangeeta T Mahajan; Sharif El-Nashar; Adonis K Hijaz
Journal:  Int Urogynecol J       Date:  2019-05-21       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.